These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31477768)

  • 1. Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA.
    Rowlands V; Rutkowski AJ; Meuser E; Carr TH; Harrington EA; Barrett JC
    Sci Rep; 2019 Sep; 9(1):12620. PubMed ID: 31477768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay.
    Lyu N; Rajendran VK; Diefenbach RJ; Charles K; Clarke SJ; Engel A; ; Rizos H; Molloy MP; Wang Y
    Nanotheranostics; 2020; 4(4):224-232. PubMed ID: 32923312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
    Janku F; Huang HJ; Fujii T; Shelton DN; Madwani K; Fu S; Tsimberidou AM; Piha-Paul SA; Wheler JJ; Zinner RG; Naing A; Hong DS; Karp DD; Cabrilo G; Kopetz ES; Subbiah V; Luthra R; Kee BK; Eng C; Morris VK; Karlin-Neumann GA; Meric-Bernstam F
    Ann Oncol; 2017 Mar; 28(3):642-650. PubMed ID: 27993791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA.
    Hussung S; Follo M; Klar RFU; Michalczyk S; Fritsch K; Nollmann F; Hipp J; Duyster J; Scherer F; von Bubnoff N; Boerries M; Wittel U; Fritsch RM
    J Mol Diagn; 2020 Jul; 22(7):943-956. PubMed ID: 32376474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interlaboratory assessment of droplet digital PCR for quantification of BRAF V600E mutation using a novel DNA reference material.
    Dong L; Wang X; Wang S; Du M; Niu C; Yang J; Li L; Zhang G; Fu B; Gao Y; Wang J
    Talanta; 2020 Jan; 207():120293. PubMed ID: 31594564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients.
    Tzanikou E; Haselmann V; Markou A; Duda A; Utikal J; Neumaier M; Lianidou ES
    Clin Chem Lab Med; 2020 Oct; 58(11):1799-1807. PubMed ID: 31953992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing.
    Vessies DCL; Greuter MJE; van Rooijen KL; Linders TC; Lanfermeijer M; Ramkisoensing KL; Meijer GA; Koopman M; Coupé VMH; Vink GR; Fijneman RJA; van den Broek D
    Sci Rep; 2020 May; 10(1):8122. PubMed ID: 32415199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations.
    Poole JC; Wu SF; Lu TT; Vibat CRT; Pham A; Samuelsz E; Patel M; Chen J; Daher T; Singh VM; Arnold LJ
    PLoS One; 2019; 14(10):e0223112. PubMed ID: 31581267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach.
    Pender A; Garcia-Murillas I; Rana S; Cutts RJ; Kelly G; Fenwick K; Kozarewa I; Gonzalez de Castro D; Bhosle J; O'Brien M; Turner NC; Popat S; Downward J
    PLoS One; 2015; 10(9):e0139074. PubMed ID: 26413866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Quantification of Plasma Circulating Tumor DNA from Melanoma Patients.
    Marsavela G; Reid A; Gray ES; Calapre L
    Methods Mol Biol; 2021; 2265():247-263. PubMed ID: 33704720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction.
    Lee JS; Kim M; Seong MW; Kim HS; Lee YK; Kang HJ
    Clin Chem Lab Med; 2020 Mar; 58(4):527-532. PubMed ID: 31874093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
    Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
    Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.
    van der Leest P; Rozendal P; Hinrichs J; van Noesel CJM; Zwaenepoel K; Deiman B; Huijsmans CJJ; van Eijk R; Speel EJM; van Haastert RJ; Ligtenberg MJL; van Schaik RHN; Jansen MPHM; Dubbink HJ; de Leng WW; Leers MPG; Tamminga M; van den Broek D; van Kempen LC; Schuuring E
    Clin Chem; 2024 May; 70(5):759-767. PubMed ID: 38484302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical validation and implementation of droplet digital PCR for the detection of BRAF mutations from cell-free DNA.
    Arnolda R; Howlett K; Chan T; Raleigh J; Hatzimihalis A; Bell A; Fellowes A; Sandhu S; McArthur GA; Fox SB; Dawson SJ; Hewitt C; Jones K; Wong SQ
    Pathology; 2022 Oct; 54(6):772-778. PubMed ID: 35618509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ultrasensitive test for profiling circulating tumor DNA using integrated comprehensive droplet digital detection.
    Ou CY; Vu T; Grunwald JT; Toledano M; Zimak J; Toosky M; Shen B; Zell JA; Gratton E; Abram TJ; Zhao W
    Lab Chip; 2019 Mar; 19(6):993-1005. PubMed ID: 30735225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification.
    Pratt ED; Cowan RW; Manning SL; Qiao E; Cameron H; Schradle K; Simeone DM; Zhen DB
    Anal Chem; 2019 Jun; 91(12):7516-7523. PubMed ID: 31072097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzymatic on/off switch-mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA.
    Wang QL; Zhou CL; Yin YF; Xiao L; Wang Y; Li K
    J Clin Lab Anal; 2020 Aug; 34(8):e23305. PubMed ID: 32207862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for circulating RAS/RAF mutations by multiplex digital PCR.
    Andersen RF; Jakobsen A
    Clin Chim Acta; 2016 Jul; 458():138-43. PubMed ID: 27181912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple, Sensitive and Accurate Multiplex Detection of Clinically Important Melanoma DNA Mutations in Circulating Tumour DNA with SERS Nanotags.
    Wee EJ; Wang Y; Tsao SC; Trau M
    Theranostics; 2016; 6(10):1506-13. PubMed ID: 27446486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.